Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: the VERTIS FACTORIAL randomized trial
These side effects vary from one person to another but can include the following mild side effects: stomach pain, heartburn, gas and bloating, nausea, vomiting, appetite loss, diarrhea, constipation, dizziness, headache, and drowsiness
Indias own surveys tell the same story: rising overweight/obesity across ages, while stunting and wasting persist in many districts
It follows the recommendation in March from NICE that the drug could be used as part of a patients treatment for obesity for the first time, in an NHS specialist weight management service and with the support of a multi-disciplinary team